Suppr超能文献

磺胺间甲氧嘧啶和乙胺嘧啶联合用药与其他药物治疗疟疾的比较。

A combination of sulfamonomethoxine and pyrimethamine versus other drugs for the treatment of malaria.

作者信息

Ebisawa I, Ohara H

出版信息

Jpn J Exp Med. 1986 Oct;56(5):213-9.

PMID:3543442
Abstract

Sixty-eight cases of vivax and 30 cases of falciparum malaria patients were treated with a combination of sulfamonomethoxine-pyrimethamine (MP tablet with 500 mg of sulfamonomethoxine and 25 mg of pyrimethamine) and the results were compared with those with chloroquine, Fansidar and quinine. Vivax malaria: Fever and parasites were cleared by the 4th day of treatment in 94 and 92% of the patients, respectively. Chloroquine was the most effective drug and Fansidar and MP tablets shared the next position. Falciparum malaria: Fever and asexual parasites were cleared by the 4th day of treatment in 67 and 78% of the patients, respectively. MP tablets were effective in chloroquine-resistant falciparum malaria contracted in Kalimantan (Indonesia) and Oceanian countries (Vanuatu etc.). Fever and parasite clearance times were shorter with chloroquine or with Fansidar than with MP tablets. Defective preschizonts used to appear following administration of MP tablets both in vivax and falciparum malarias. They were the premonitory laboratory indications that the asexual parasites will be soon eradicated.

摘要

68例间日疟患者和30例恶性疟患者接受了磺胺间甲氧嘧啶-乙胺嘧啶联合治疗(每片含500毫克磺胺间甲氧嘧啶和25毫克乙胺嘧啶的MP片),并将结果与使用氯喹、Fansidar和奎宁治疗的结果进行比较。间日疟:治疗第4天时,分别有94%和92%的患者发热和疟原虫被清除。氯喹是最有效的药物,Fansidar和MP片并列第二。恶性疟:治疗第4天时,分别有67%和78%的患者发热和无性疟原虫被清除。MP片对在加里曼丹(印度尼西亚)和大洋洲国家(瓦努阿图等)感染的耐氯喹恶性疟有效。氯喹或Fansidar清除发热和疟原虫的时间比MP片短。服用MP片后,间日疟和恶性疟中均会出现有缺陷的裂殖体前期。它们是无性疟原虫即将被根除的先兆实验室指标。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验